Winner Medical Co., Ltd. (300888.SZ)
CNY 40.96
(0.1%)
CNY 40.96
(0.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.21 Billion CNY | -30.93% |
| 2022 | -1.68 Billion CNY | 54.05% |
| 2021 | -3.67 Billion CNY | 8.39% |
| 2020 | -4.01 Billion CNY | -1743.54% |
| 2019 | -217.65 Million CNY | -118.47% |
| 2018 | -99.62 Million CNY | -90.96% |
| 2017 | -52.17 Million CNY | 80.46% |
| 2016 | -267.06 Million CNY | -65.03% |
| 2015 | -161.83 Million CNY | -371.47% |
| 2014 | -34.32 Million CNY | -130.93% |
| 2013 | 110.96 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.69 Billion CNY | -11.3% |
| 2024 Q3 | -1.17 Billion CNY | 30.73% |
| 2024 Q1 | -1.52 Billion CNY | 31.15% |
| 2023 Q3 | -1.8 Billion CNY | 5.48% |
| 2023 FY | -2.21 Billion CNY | -30.93% |
| 2023 Q4 | -2.21 Billion CNY | -22.86% |
| 2023 Q1 | -1.27 Billion CNY | 24.81% |
| 2023 Q2 | -1.9 Billion CNY | -49.95% |
| 2022 Q3 | -1.36 Billion CNY | 45.35% |
| 2022 Q1 | -3.2 Billion CNY | 12.92% |
| 2022 FY | -1.68 Billion CNY | 54.05% |
| 2022 Q4 | -1.68 Billion CNY | -23.31% |
| 2022 Q2 | -2.5 Billion CNY | 21.69% |
| 2021 Q4 | -3.67 Billion CNY | 4.04% |
| 2021 Q2 | -4.08 Billion CNY | -3.87% |
| 2021 Q1 | -3.93 Billion CNY | 2.02% |
| 2021 FY | -3.67 Billion CNY | 8.39% |
| 2021 Q3 | -3.83 Billion CNY | 6.19% |
| 2020 Q3 | -7.14 Billion CNY | -235.9% |
| 2020 FY | -4.01 Billion CNY | -1743.54% |
| 2020 Q2 | -2.12 Billion CNY | -542.16% |
| 2020 Q4 | -4.01 Billion CNY | 43.81% |
| 2020 Q1 | 480.83 Million CNY | 320.92% |
| 2019 Q1 | -10.51 Million CNY | 0.0% |
| 2019 FY | -217.65 Million CNY | -118.47% |
| 2019 Q4 | -217.65 Million CNY | 0.0% |
| 2019 Q2 | -5.52 Million CNY | 47.48% |
| 2018 FY | -99.62 Million CNY | -90.96% |
| 2017 FY | -52.17 Million CNY | 80.46% |
| 2016 FY | -267.06 Million CNY | -65.03% |
| 2015 FY | -161.83 Million CNY | -371.47% |
| 2014 FY | -34.32 Million CNY | -130.93% |
| 2013 FY | 110.96 Million CNY | 0.0% |